Form 4: Nu Skin Director Edwina Woodbury Trades Shares
Statement of Changes in Beneficial Ownership
Nu Skin Enterprises, Inc. director Edwina D. Woodbury reported transactions involving Class A Common Stock, executed under a Rule 10b5-1 trading plan.
Summary
- Edwina D. Woodbury, a Director at Nu Skin Enterprises, Inc. (NUS), has reported transactions involving Class A Common Stock.
- These transactions were executed under a pre-arranged trading plan designed to comply with Rule 10b5-1(c), adopted on February 19, 2026.
- On June 1, 2026, 26,643 shares of Class A Common Stock were acquired at a price of $0.00, resulting in a total of 69,636 shares beneficially owned.
- Additionally, on the same date, 7,203 shares of Class A Common Stock were disposed of at a price of $5.70 per share, leaving 62,433 shares beneficially owned.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it involves stock transactions by a director, the execution under a Rule 10b5-1 plan suggests a pre-planned strategy rather than a reaction to current company performance or outlook.
Positives
- The transactions were conducted under a Rule 10b5-1 trading plan, indicating a pre-determined and structured approach to stock trading, which can mitigate insider trading concerns.
- The acquisition of shares at $0.00 suggests these may be performance awards or grants, which could align with executive compensation structures.
Negatives
- The disposal of 7,203 shares indicates a reduction in direct beneficial ownership by the director.
- The sale price of $5.70 per share might be lower than the current market price, though this filing does not provide market context.
Risks
- The disposal of shares by a director could be interpreted negatively by the market, potentially signaling a lack of confidence in future stock performance, although the Rule 10b5-1 plan mitigates this interpretation to some extent.
- The specific reasons for the disposal are not detailed, leaving room for speculation.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. The Rule 10b5-1 plan indicates a structured approach to future trading, but specific outcomes are not projected.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan is a common strategy for executives to manage their stock holdings while adhering to regulations, particularly in the direct selling and beauty products industry where Nu Skin operates.
Stakeholder Impact
- Shareholders: May observe the director's stock transactions, but the Rule 10b5-1 plan is designed to reduce the impact of such trades on market perception.
- Employees: The transactions do not directly impact employee compensation or operations.
- Management: The plan allows management to diversify or manage personal finances while complying with regulations.
Next Steps
- Continued adherence to the Rule 10b5-1 trading plan by Edwina D. Woodbury.
- Monitoring of future Form 4 filings for any further transactions by Nu Skin Enterprises' insiders.
Key Dates
| Date | Description |
|---|---|
| 02/19/2026 | Date the Rule 10b5-1 trading plan was adopted. |
| 06/01/2026 | Date of the reported stock acquisition and disposal transactions. |
| 06/03/2026 | Date the Form 4 filing was signed. |
Keywords
Nu Skin Enterprises, NUS, Form 4, Insider Trading, Rule 10b5-1, Class A Common Stock, Director Transactions, Beneficial Ownership, Stock Disposal, Stock Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.